Our studies show that HIV-1, HIV-2, and HTLV-I infection all provoke a progressive defect in surface T cell receptor expression. A specific loss of CD3γ transcripts is responsible for the defect after HIV-1 or HIV-2 infection. Alternatively, while CD3γ transcripts are lost first after HTLV-I infection, their reduction is followed several months later by a loss of CD3δ and subsequently CD3ε mRNA. Studies of CD3γ transcriptional control revealed parallels with elements regulating HIV-1 gene expression, including a downstream element reminiscent of HIV TAR. Mutant and deletion CD3γ promoter constructs delimited a 53 bp region downstream from the major transcription start site as critical for positive gene expression. EMSA experiments demonstrate that this sequence functions through an RNA rather than a DNA intermediate, which can bind three specific nuclear protein complexes. Deletion of U at +9 and +37 kills promoter activity. Alternatively, progressive silencing of the CD3 gene locus by HTLV-I functions via chromatin remodeling, characterized by increased binding of Ikaros to the CD3 γ promoter and the CD3δ enhancer. Expression of the CD3 genes can be reactivated in HTLV-I infected cells by the synergistic action of the histone deactylase inhibitor trichostatin A and the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine. The importance of viral targeting of the CD3 genes will be discussed. [link 'here' using 'a href' to: <url>http://www.biomedcentral.com/content/pdf/1742-4690-2-S1-full.pdf</url>]</note> </supplement>
